Items tagged with Drug-resistant TB
Promising first results with a 9-month regimen for multidrug-resistant tuberculosis in French-speaking African countries (post)
Good preliminary results from an observational trial of a 9-month regimen for multidrug-resistant (MDR) TB conducted in francophone Africa were presented at the 46th World Health Conference on Lung Health of the International Union Against Tuberculosis and Lung Disease (The Union).
Obama proposes less money to fight world's top infectious killer (post)
WASHINGTON -- Less than two months after unveiling a plan to fight multidrug-resistant tuberculosis, President Barack Obama has proposed cutting the U.S. Agency for International Development's funding to combat the world's No. 1 infectious killer -- by 19 percent.
When my brother got TB, doctors said there was no hope. How could that be? (post)
Two years ago a hospital administrator confirmed that my brother Gary had tuberculosis. Then she told us the bad news.
India: Spluttering against TB (post)
In a small, airless room in Dharavi, Owais sat chatting with his wife and two children. Outside, the famous rains of Mumbai beat down relentlessly on the thousands of tiny rooms that dot Dharavi.
Antimicrobial resistance and the growing threat of drug-resistant tuberculosis (post)
Antimicrobial resistance (AMR) is a global health emergency, and experts are concerned that the end of the age of antimicrobials is imminent [1], [2], [3], [4], [5] and [6]. Since the introduction of antimicrobials nearly a century ago, microbes have evolved a variety of methods to resist these drugs. Today, the world is dealing with ‘superbugs’ that are virtually untreatable, including drug-resistant gonorrhea, carbapenem-resistant enterobacteriaceae, Methicillin-resistant Staphylococcus aureus, and extended-spectrum-beta-lactamase producing strains [5]. The antibiotic pipeline is running dry, and AMR is threatening to undo major gains made in the control of infectious diseases. Models suggest that 300 million people are expected to die prematurely because of AMR over the next 35 years and the world’s GDP will be 2–3.5% lower than it otherwise would be in 2050 [6]. This translates into a loss of 60–100 trillion USD worth of economic output by 2050.
Factors associated with TB and rifampicin-resistant TB amongst symptomatic patients in India: a retrospective analysis (post)
Abstract
Direct transmission seems to drive XDR-TB (post)
BOSTON, February 28 -- A person-by-person tracing process pinpointed transmission of extensively drug-resistant tuberculosis (XDR-TB) to households and hospitals, researchers reported here.
Bedaquiline plus delamanid for XDR tuberculosis (post)
We read with interest the correspondence by Caitlin Reed and colleagues, reporting a patient with a severe case of extensively drug-resistant (XDR) tuberculosis who was treated with bedaquiline and subsequently denied delamanid because of concerns over additive cardiac toxic effects.1 Here we report the case of a man with XDR tuberculosis who was treated with a regimen containing bedaquiline and delamanid in combination.
Page 25 of 117 · Total posts: 0
←First 24 25 26 Last→